Annual Total Liabilities
$1.76 M
-$1.38 M-43.98%
31 December 2023
Summary:
Monopar Therapeutics annual total liabilities is currently $1.76 million, with the most recent change of -$1.38 million (-43.98%) on 31 December 2023. During the last 3 years, it has risen by +$580.70 thousand (+49.35%). MNPR annual total liabilities is now -43.98% below its all-time high of $3.14 million, reached on 31 December 2022.MNPR Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$1.12 M
+$33.40 K+3.07%
30 September 2024
Summary:
Monopar Therapeutics quarterly total liabilities is currently $1.12 million, with the most recent change of +$33.40 thousand (+3.07%) on 30 September 2024. Over the past year, it has dropped by -$858.90 thousand (-43.34%). MNPR quarterly total liabilities is now -64.21% below its all-time high of $3.14 million, reached on 31 December 2022.MNPR Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MNPR Total Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -44.0% | -43.3% |
3 y3 years | +49.4% | -9.4% |
5 y5 years | +339.8% | +132.2% |
MNPR Total Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -44.0% | +49.4% | -64.2% | +3.1% |
5 y | 5 years | -44.0% | +339.8% | -64.2% | +153.2% |
alltime | all time | -44.0% | +2624.7% | -64.2% | +286.4% |
Monopar Therapeutics Total Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $1.12 M(+3.1%) |
June 2024 | - | $1.09 M(-24.1%) |
Mar 2024 | - | $1.44 M(-18.3%) |
Dec 2023 | $1.76 M(-44.0%) | $1.76 M(-11.3%) |
Sept 2023 | - | $1.98 M(-20.8%) |
June 2023 | - | $2.50 M(-13.4%) |
Mar 2023 | - | $2.89 M(-8.0%) |
Dec 2022 | $3.14 M(+98.5%) | $3.14 M(+62.1%) |
Sept 2022 | - | $1.94 M(-12.8%) |
June 2022 | - | $2.22 M(+101.9%) |
Mar 2022 | - | $1.10 M(-30.4%) |
Dec 2021 | $1.58 M | $1.58 M(+27.5%) |
Sept 2021 | - | $1.24 M(+12.4%) |
June 2021 | - | $1.10 M(+36.9%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2021 | - | $806.30 K(-31.5%) |
Dec 2020 | $1.18 M(+62.5%) | $1.18 M(+77.1%) |
Sept 2020 | - | $664.50 K(+2.5%) |
June 2020 | - | $648.10 K(+46.1%) |
Mar 2020 | - | $443.50 K(-38.8%) |
Dec 2019 | $724.20 K(+81.2%) | $724.20 K(+49.7%) |
Sept 2019 | - | $483.70 K(+3.3%) |
June 2019 | - | $468.30 K(-19.3%) |
Mar 2019 | - | $580.00 K(+45.1%) |
Dec 2018 | $399.60 K(+28.1%) | $399.60 K(+28.1%) |
Sept 2018 | - | $311.90 K(-3.5%) |
June 2018 | - | $323.10 K(+11.2%) |
Mar 2018 | - | $290.60 K(-6.8%) |
Dec 2017 | $311.90 K(+383.6%) | $311.90 K |
Dec 2016 | $64.50 K | - |
FAQ
- What is Monopar Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Monopar Therapeutics?
- What is Monopar Therapeutics annual total liabilities year-on-year change?
- What is Monopar Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Monopar Therapeutics?
- What is Monopar Therapeutics quarterly total liabilities year-on-year change?
What is Monopar Therapeutics annual total liabilities?
The current annual total liabilities of MNPR is $1.76 M
What is the all time high annual total liabilities for Monopar Therapeutics?
Monopar Therapeutics all-time high annual total liabilities is $3.14 M
What is Monopar Therapeutics annual total liabilities year-on-year change?
Over the past year, MNPR annual total liabilities has changed by -$1.38 M (-43.98%)
What is Monopar Therapeutics quarterly total liabilities?
The current quarterly total liabilities of MNPR is $1.12 M
What is the all time high quarterly total liabilities for Monopar Therapeutics?
Monopar Therapeutics all-time high quarterly total liabilities is $3.14 M
What is Monopar Therapeutics quarterly total liabilities year-on-year change?
Over the past year, MNPR quarterly total liabilities has changed by -$858.90 K (-43.34%)